This inventor holds 1 USPTO granted patent. Top assignees: Instituto Nazionale Per Lo Studio E La Cura Dei Tumori, Sigma-Tau Industrie Farmaceutiche Riunite S.p.a.. Active years: 2007.
Company Filing History:
1 out of 3 
1 out of 343 
Years Active: 2007
Title: Penco Sergio: Innovator in Pharmaceutical Chemistry
Introduction
Penco Sergio is a notable inventor based in Rome, Italy. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that serve as topoisomerase I inhibitors. His work has implications for cancer treatment, showcasing the intersection of innovation and healthcare.
Latest Patents
Penco Sergio holds a patent for "Camptothecins with a modified lactone ring." This patent describes compounds of formula (I) or (II), where the groups are defined in the detailed description. The patent encompasses racemic mixtures, individual enantiomers, individual diastereoisomers, their mixtures, and pharmaceutically acceptable salts. These compounds are recognized for their role as topoisomerase I inhibitors, which are crucial in cancer therapy.
Career Highlights
Throughout his career, Penco has worked with esteemed organizations such as the National Institute for the Study and Treatment of Tumors and Sigma-Tau Industrie Farmaceutiche Riunite S.p.a. His experience in these institutions has allowed him to contribute to significant advancements in cancer research and treatment.
Collaborations
Penco has collaborated with notable colleagues, including Zunino Franco and Vergani Domenico. These partnerships have fostered a collaborative environment that enhances innovation and research in the pharmaceutical field.
Conclusion
Penco Sergio's contributions to pharmaceutical chemistry, particularly through his patent on camptothecins, highlight his role as an innovator in cancer treatment. His collaborations and career achievements reflect a commitment to advancing healthcare through scientific research.